Diagnosis and Management of Immunotherapy-related Liver Toxicity
Immune checkpoint inhibitors have revolutionized the treatment of cancer. With the increasing use of immunotherapy, clinicians have observed that immunotherapy is often related to a spectrum of adverse events. Liver toxicity is one of the most common and severe immune-related adverse events. It is v...
Guardado en:
Autores principales: | HUA Yuwei, ZHAO Lin |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fedbee7a61344b0c8c947a5280bf250b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
por: Xiujing He, et al.
Publicado: (2021) -
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Pan Shen, et al.
Publicado: (2021) -
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab
por: Rosaria De Filippi, et al.
Publicado: (2021) -
Risk factors for immune-related adverse events: what have we learned and what lies ahead?
por: Xiaoyan Liu, et al.
Publicado: (2021) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Di Wang, et al.
Publicado: (2021)